The mechanism of action of ALDH1L2 in human HCC remains unclear; however, in canine HCC, SLPI, DUSP9, and ALDH1L2 may be involved in the MAPK pathway. The gene discussed is ALDH1L2; the disease is hepatocellular carcinoma.